Added to YB: 2025-06-10
Pitch date: 2025-06-08
ETON [bullish]
Eton Pharmaceuticals, Inc.
+6.05%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
Market Cap
$451.3M
Pitch Price
$17.18
Price Target
29.67 (+63%)
Dividend
N/A
EV/EBITDA
93.16
P/E
-65.04
EV/Sales
6.33
Sector
Pharmaceuticals
Category
growth
Show full summary:
Three small-cap ideas could generate significant returns in the future. - Eton Pharmaceuticals, Inc.
ETON: Specialty pharma w/ 7 rare disease products showing 17 quarters of sequential growth. Q1'25 revenue $17.3M (product sales +76% YoY), beat EPS est. New FDA-approved Khindivi targets $200M market. ET-600 NDA filed April'25. 10 products by YE'25 targeted. $29.67 PT (76% upside) despite high 9.12x P/S.
Read full article (2 min)